Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
J Immunol ; 186(5): 3093-103, 2011 Mar 01.
Article in English | MEDLINE | ID: mdl-21263070

ABSTRACT

Hepatitis C virus (HCV) dysregulates innate immune responses and induces persistent viral infection. We previously demonstrated that HCV core protein impairs IL-12 expression by monocytes/macrophages (M/M(Φ)s) through interaction with a complement receptor gC1qR. Because HCV core-mediated lymphocyte dysregulation occurs through the negative immunomodulators programmed death-1 (PD-1) and suppressor of cytokine signaling-1 (SOCS-1), the aim of this study was to examine their role in HCV core-mediated IL-12 suppression in M/M(Φ)s. We analyzed TLR-stimulated, primary CD14(+) M/M(Φ)s from chronically HCV-infected and healthy subjects or the THP-1 cell line for PD-1, SOCS-1, and IL-12 expression following HCV core treatment. M/M(Φ)s from HCV-infected subjects at baseline exhibited comparatively increased PD-1 expression that significantly correlated with the degree of IL-12 inhibition. M/M(Φ)s isolated from healthy and HCV-infected individuals and treated with HCV core protein displayed increased PD-1 and SOCS-1 expression and decreased IL-12 expression, an effect that was also observed in cells treated with gC1qR's ligand, C1q. Blocking gC1qR rescued HCV core-induced PD-1 upregulation and IL-12 suppression, whereas blocking PD-1 signaling enhanced IL-12 production and decreased the expression of SOCS-1 induced by HCV core. Conversely, silencing SOCS-1 expression using small interfering RNAs increased IL-12 expression and inhibited PD-1 upregulation. PD-1 and SOCS-1 were found to associate by coimmunoprecipitation studies, and blocking PD-1 or silencing SOCS-1 in M/M(Φ) led to activation of STAT-1 during TLR-stimulated IL-12 production. These data suggested that HCV core/gC1qR engagement on M/M(Φ)s triggers the expression of PD-1 and SOCS-1, which can associate to deliver negative signaling to TLR-mediated pathways controlling expression of IL-12, a key cytokine linking innate and adaptive immunity.


Subject(s)
Antigens, CD/physiology , Apoptosis Regulatory Proteins/physiology , Cell Communication/immunology , Hepatitis C, Chronic/immunology , Hepatitis C, Chronic/metabolism , Interleukin-12/antagonists & inhibitors , Macrophages/immunology , Monocytes/immunology , Suppressor of Cytokine Signaling Proteins/physiology , Adult , Aged , Cell Line, Tumor , Down-Regulation/immunology , Female , Hepatitis C, Chronic/pathology , Humans , Interleukin-12/biosynthesis , Macrophages/metabolism , Macrophages/pathology , Male , Membrane Glycoproteins/metabolism , Middle Aged , Monocytes/metabolism , Monocytes/pathology , Programmed Cell Death 1 Receptor , Receptors, Complement/metabolism , Suppressor of Cytokine Signaling 1 Protein , Toll-Like Receptors/physiology
2.
Immunol Cell Biol ; 89(4): 535-9, 2011 May.
Article in English | MEDLINE | ID: mdl-20975732

ABSTRACT

T regulatory (T(R)) cells suppress T-cell responses that are critical in the development of chronic viral infection and associated malignancies. Programmed death-1 (PD-1) also has a pivotal role in regulation of T-cell functions during chronic viral infection. To examine the role of PD-1 pathway in regulating T(R)-cell functions that inhibit T-cell responses during virus-associated malignancy, T(R) cells were investigated in the setting of hepatitis C virus-associated lymphoma (HCV-L), non-HCV-associated lymphoma (non-HCV-L), HCV infection alone and healthy subjects (HS). Relatively high numbers of CD4(+)CD25(+) and CD8(+)CD25(+) T(R) cells, as well as high levels of PD-1 expressions on these T(R) cells were found in the peripheral blood of subjects with HCV-L compared with those from non-HCV-L or HCV alone or HS. T(R) cells from the HCV-L subjects were capable of suppressing the autogeneic lymphocyte response, and depletion of T(R) cells in peripheral blood mononuclear cells from HCV-L improved T-cell proliferation. Additionally, the suppressed T-cell activation and proliferation in HCV-L was partially restored by blocking the PD-1 pathway ex vivo, resulting in both a reduction in T(R)-cell number and the ability of T(R) to suppress the activity of effector T cells. This study suggests that the PD-1 pathway is involved in regulating T(R) cells that suppress T-cell functions in the setting of HCV-associated B-cell lymphoma.


Subject(s)
Antigens, CD/metabolism , Apoptosis Regulatory Proteins/metabolism , Hepatitis C, Chronic/immunology , Lymphoma/immunology , T-Lymphocytes, Regulatory/immunology , T-Lymphocytes/immunology , Adult , Aged , Antibodies, Monoclonal/immunology , Apoptosis Regulatory Proteins/antagonists & inhibitors , Cell Proliferation , Cells, Cultured , Hepatitis C, Chronic/complications , Humans , Lymphocyte Activation/immunology , Lymphoma/complications , Lymphoma/virology , Male , Middle Aged , Programmed Cell Death 1 Receptor , Signal Transduction/immunology , T-Lymphocytes/virology
3.
J Biomed Biotechnol ; 2010: 141657, 2010.
Article in English | MEDLINE | ID: mdl-20379365

ABSTRACT

Immune induction by successful vaccine formulations seems to involve stimulation of both humoral and cellular arms of immunity. Nevertheless, CD8+ CTLs are of critical relevance in the context of intracellular infection and tumor for many reasons. The task of exerting antipathogen activity by CD8+ T cells, which principally function to control and eradicate intracellular pathogens, is enabled by constitutive expression of MHC class-I molecules on all tissue types. CTL induction offers hope for vaccines against pathogens that are resistant to neutralizing activity. This review discusses the mechanism of immune induction by some successful vaccines and based on the accrued evidence suggests ideas for improved design of CTL-inducing vaccines.


Subject(s)
T-Lymphocytes, Cytotoxic/immunology , Viral Vaccines/immunology , Acute Disease , Animals , B-Lymphocytes/immunology , Chronic Disease , Humans , Lymphocyte Activation/immunology
4.
Cell Immunol ; 261(2): 114-21, 2010.
Article in English | MEDLINE | ID: mdl-20022593

ABSTRACT

A memory response is established following primary antigen exposure that stays more or less constant. It appears to adopt a set-point in magnitude but upon re-exposure the response is quicker and better and there is an upward shift in memory frequency that varies with individuals based on the exposure pattern to other microbes or its components. Our investigations were designed to test such differences of non-specific stimulation by PAMPs in lowering the threshold of activation. Neonatal mice were pre-exposed to TLR-ligands intermittently and later analyzed for its resilience to challenge with virus during adult-life. Secondly, adult mice with pre-existing memory to virus were exposed to various TLR-ligands and analyzed for their quality of memory response. The TLR-ligands exposed animals were better responders to a new agent exposure compared to the animals kept in sterile surroundings. Moreover, immune memory recall and the viral specific CD8(+) T cells response with TLR-ligands were comparable to the recall response with the cognate antigen. The results provide insights into the role of hyper-sanitized environment versus PAMPs mediated signaling in adaptive immunity and long-term immune memory.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , Herpesvirus 1, Human/immunology , Ligands , Toll-Like Receptors/immunology , Adaptive Immunity/immunology , Adult , Animals , Animals, Newborn , Child , Humans , Immunologic Memory/immunology , Mice , Mice, Inbred C57BL , Signal Transduction/immunology , Spleen/cytology , Survival Rate
5.
Clin Mol Allergy ; 7: 5, 2009 Mar 12.
Article in English | MEDLINE | ID: mdl-19284628

ABSTRACT

Dysregulated immune response results in inflammatory symptoms in the respiratory mucosa leading to asthma and allergy in susceptible individuals. The T helper type 2 (Th2) subsets are primarily involved in this disease process. Nevertheless, there is growing evidence in support of T cells with regulatory potential that operates in non-allergic individuals. These regulatory T cells occur naturally are called natural T regulatory cells (nTregs) and express the transcription factor Foxp3. They are selected in the thymus and move to the periphery. The CD4 Th cells in the periphery can be induced to become regulatory T cells and hence called induced or adaptive T regulatory cells. These cells can make IL-10 or TGF-b or both, by which they attain most of their suppressive activity. This review gives an overview of the regulatory T cells, their role in allergic diseases and explores possible interventionist approaches to manipulate Tregs for achieving therapeutic goals.

6.
Mol Immunol ; 46(7): 1494-504, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19233474

ABSTRACT

The recurrence of lesions and transmission of Herpes simplex virus is dependent on the number and function of viral specific CD8(+) T cells, especially the memory T cells. The generation, turnover and set point of this cell population is maintained by different factors like exposure to antigen, cytokines and co-stimulatory molecules. However, the contribution of these factors in the generation and maintenance of the memory CD8(+) T cell population is still controversial, since it is not clear if homeostatic proliferation driven by cytokines can overcome T cell receptor (TCR) signaling. Since, interleukin 15 (IL-15) and interleukin 21 (IL-21) are cytokines implicated in homeostatic control of CD8(+) T cell pool, we constructed and used expression plasmids coding for IL-15 (pIL-15) and IL-21 (pIL-21) to expand HSV specific CD8(+) T cells in an animal model. Our results showed that the IL-21 increased the frequency of CD8(+) T cells in the absence of antigen, although the magnitude of this response was dependent on TCR signaling. Both pIL-15 and pIL-21 boosted the numbers of antigen specific CD8(+) IFNgamma producing cells in the primary response. In the memory phase, numbers of CD8(+) CD44(high) as well as CD8(+) T cells producing IFN-gamma and TNF-alpha were increased when pIL-15 and pIL-21 were used alone or in combination, compared to vector treatment only, and association of antigen further increased the proliferative response. Our data suggest that genetic treatment with pIL-15 and pIL-21 in the presence or absence of cognate antigen can contribute to immune-enhancement against HSV.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , DNA/immunology , Immunologic Memory , Interleukin-15/immunology , Interleukins/immunology , Simplexvirus/immunology , T-Lymphocytes/immunology , Animals , Cells, Cultured , Chlorocebus aethiops , DNA/physiology , Female , Genetic Therapy , Humans , Immunologic Memory/physiology , Immunotherapy/methods , Interleukin-15/genetics , Interleukins/genetics , Mice , Mice, Inbred C57BL , Mice, Transgenic , Rats , T-Cell Antigen Receptor Specificity , Vero Cells
7.
J Virol ; 82(21): 10820-31, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18715907

ABSTRACT

Innate defenses help to eliminate infection, but some of them also play a major role in shaping the magnitude and efficacy of the adaptive immune response. With regard to influencing subsequent adaptive immunity, NK cells aided by dendritic cells may be the most relevant components of the innate reaction to herpes simplex virus (HSV) infection. We confirm that mice lacking or depleted of NK cells are susceptible to HSV-induced lesions. The quantity and quality of CD8(+) cytotoxic T lymphocytes generated in the absence of NK cells were diminished, thereby contributing to susceptibility to HSV-induced encephalitis. We demonstrate a novel helper role for NK cells, in that NK cells compensate for the loss of CD4 helper T cells and NK cell supplementation enhances the function of wild type anti-HSV CD8 T cells. In addition, NK cells were able to partially rescue the dysfunctional CD8(+) T cells generated in the absence of CD4 T helper cells, thereby performing a novel rescue function. Hence, NK cells may well be exploited for enhancing and rescuing the T-cell response in situations where the CD4 helper response is affected.


Subject(s)
Herpesvirus 1, Human/immunology , Killer Cells, Natural/immunology , T-Lymphocytes, Helper-Inducer/immunology , Animals , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Cell Line , Chlorocebus aethiops , Encephalitis, Viral/immunology , Leukocyte Reduction Procedures , Mice , Mice, Inbred C57BL , Mice, Knockout
8.
J Immunol ; 172(7): 4123-32, 2004 Apr 01.
Article in English | MEDLINE | ID: mdl-15034024

ABSTRACT

CD4(+)CD25(+) regulatory T cells (T(reg)) can inhibit a variety of autoimmune and inflammatory diseases, but their involvement in regulating virus-induced immunopathology is not known. We have evaluated the role of T(reg) in viral immunopathological lesion stromal keratitis. This frequent cause of human blindness results from a T cell-mediated immunoinflammatory response to HSV in the corneal stroma. The results show that lesions were significantly more severe if mice were depleted of T(reg) before infection. The T(reg) was also shown to modulate lesion expression induced by adoptive transfer of pathogenic CD4(+) T cells in infected SCID recipients. The mechanism of T(reg) control of stromal keratitis involved suppressed antiviral immunity and impaired expression of the molecule required for T cell migration to lesion sites. Interestingly, T(reg) isolated from ocular lesions in nondepleted mice showed in vitro inhibitory effects involving IL-10, but were not very effective in established lesions. Our results decipher the in vivo role of T(reg) in a virus-induced immunopathology and imply that manipulation of regulatory cell function represents a useful approach to control viral-induced immunoinflammatory disease.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , Herpesvirus 1, Human/immunology , Keratitis, Herpetic/immunology , Keratitis, Herpetic/pathology , Receptors, Interleukin-2/biosynthesis , T-Lymphocyte Subsets/immunology , Adoptive Transfer , Animals , CD4-Positive T-Lymphocytes/metabolism , CD4-Positive T-Lymphocytes/pathology , CD4-Positive T-Lymphocytes/transplantation , Cell Movement/immunology , Cells, Cultured , Female , Immunophenotyping , Immunosuppression Therapy , Keratitis, Herpetic/prevention & control , Lymphocyte Depletion , Lymphopenia/immunology , Lymphopenia/pathology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, SCID , Receptors, Interleukin-2/administration & dosage , Severity of Illness Index , T-Lymphocyte Subsets/metabolism , T-Lymphocyte Subsets/pathology , T-Lymphocyte Subsets/transplantation
9.
J Exp Med ; 198(6): 889-901, 2003 Sep 15.
Article in English | MEDLINE | ID: mdl-12975455

ABSTRACT

Naturally occurring CD4+CD25+ regulatory T cells appear important to prevent activation of autoreactive T cells. This article demonstrates that the magnitude of a CD8+ T cell-mediated immune response to an acute viral infection is also subject to control by CD4+CD25+ T regulatory cells (Treg). Accordingly, if natural Treg were depleted with specific anti-CD25 antibody before infection with HSV, the resultant CD8+ T cell response to the immunodominant peptide SSIEFARL was significantly enhanced. This was shown by several in vitro measures of CD8+ T cell reactivity and by assays that directly determine CD8+ T cell function, such as proliferation and cytotoxicity in vivo. The enhanced responsiveness in CD25-depleted animals was between three- and fourfold with the effect evident both in the acute and memory phases of the immune response. Surprisingly, HSV infection resulted in enhanced Treg function with such cells able to suppress CD8+ T cell responses to both viral and unrelated antigens. Our results are discussed both in term of how viral infection might temporarily diminish immunity to other infectious agents and their application to vaccines. Thus, controlling suppressor effects at the time of vaccination could result in more effective immunity.


Subject(s)
CD4-Positive T-Lymphocytes/metabolism , CD8-Positive T-Lymphocytes/metabolism , Herpes Simplex/immunology , Immunologic Memory/physiology , Receptors, Interleukin-2/metabolism , T-Lymphocyte Subsets/metabolism , Adoptive Transfer , Animals , Biomarkers , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Female , Herpes Simplex/metabolism , Herpesvirus 1, Human/immunology , Herpesvirus 1, Human/metabolism , Lymphocyte Activation , Mice , Mice, Inbred C57BL , Receptors, Interleukin-2/immunology , T-Lymphocyte Subsets/immunology
10.
J Virol ; 76(13): 6568-76, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12050369

ABSTRACT

Oligodeoxynucleotides (ODN) containing unmethylated CpG motifs exert powerful adjuvant activity in vivo and in vitro. Administered with antigen they induce a population of antigen-specific CD8+ T cells. In this study we immunized C57BL/6 mice with bioactive CpG ODN combined with an immunodominant epitope derived from herpes simplex virus (HSV) glycoprotein B (amino acids 498 to 505; SSIEFARL) and analyzed the magnitude and durability of the peptide-specific response. The effectiveness of the CD8+ T-cell response as measured by peptide-specific tetramers, peptide-induced intracellular gamma interferon expression, and resistance to systemic and mucosal challenge during the acute and memory phases was compared with the response induced by immunization with recombinant vaccinia virus encoding SSIEFARL as a minigene (VvgB(498-505)). Confirming the reports of others, our results demonstrate that the CpG ODN-peptide approach generates an antigen-specific CD8+ T-cell population, but the frequency of CD8+ T cells is lower than that induced by VvgB(498-505). Nevertheless, the protection level was comparable when mice were systemically and mucosally challenged during the acute phase. However, such responses by both groups waned with time and were functionally less effective. Still, our results indicate that the CpG ODN-peptide immunization system holds promise as a means of selectively inducing a CD8+ T-cell response against HSV.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , Dinucleoside Phosphates/immunology , Herpes Simplex/immunology , Herpesvirus 1, Human/immunology , Herpesvirus Vaccines/immunology , Peptides/immunology , Viral Envelope Proteins/immunology , Animals , Dinucleoside Phosphates/chemistry , Female , Herpes Simplex/prevention & control , Herpesvirus 1, Human/pathogenicity , Immunity, Mucosal , Immunodominant Epitopes/chemistry , Immunologic Memory , Mice , Mice, Inbred C57BL , Peptides/chemistry , Vaccination , Vagina/immunology , Vagina/virology , Viral Envelope Proteins/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...